Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.60%
#6 Bedrock Bedrock +71.13%
#7 Cysic Cysic +42.73%
#8 Prom Prom +38.17%
#9 COTI COTI +34.60%
#10 Playnance Playnance +34.46%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
GlobeImmune, Inc. GlobeImmune, Inc.

GlobeImmune, Inc.

GBIM
Classement en actions #42634
GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and... GlobeImmune, Inc., a biopharmaceutical firm based in Louisville, Colorado, and founded in 1995 (originally Ceres Pharmaceuticals, Inc. until its rebranding in May 2001), specializes in creating therapeutic products for both cancer and infectious diseases. Central to its development efforts is its unique Tarmogen platform. The company's pipeline includes several key candidates: For infectious diseases: GS-4774 is currently in Phase 2 clinical trials, designed to treat individuals chronically infected with the hepatitis B virus who are also on oral antiviral suppressive therapy. Additionally, GlobeImmune has various other infectious disease programs in the preclinical stage, such as GI-19000 for tuberculosis, GI-2010 for human immunodeficiency virus (HIV), and GI-18000 for hepatitis D virus infections. For oncology: GlobeImmune is advancing GI-6301, which targets cancers characterized by the expression of the brachyury protein. GI-6207 is progressing through Phase 2 clinical trials for medullary thyroid cancer. Furthermore, GI-4000 is a significant asset, undergoing Phase 2b clinical trials for resected pancreatic cancer, and is also in separate Phase 2 trials for non-small cell lung cancer and colorectal cancer. To support its endeavors, GlobeImmune maintains strategic alliances with industry leaders such as Gilead Sciences, Inc. and Celgene Corporation.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$575.00
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange GlobeImmune, Inc. (GBIM)

Catégorie

Healthcare
Le prix GBIM avec la capitalisation boursière de B
GlobeImmune, Inc. GlobeImmune, Inc.
GBIM
$0.0001
Capitalisation boursière de GlobeImmune, Inc.(GBIM)
Capitalisation boursière: $575.00
En August 2026, GlobeImmune, Inc. a une capitalisation boursière de $575.00. Cela fait de GlobeImmune, Inc. la 42634th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de GlobeImmune, Inc. du 2014 au 2026
GBIM par rapport au top 5 des plus populaires stocks
Prix pour GBIM L’actif B La capitalisation boursière de B Résultats
GlobeImmune, Inc. GlobeImmune, Inc.
$943,650 $575.00
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.426T +943,650,177,897.04%
GlobeImmune, Inc. GlobeImmune, Inc.
$769,898 $575.00
Apple Inc. Apple Inc.
AAPL
$4.427T +769,898,429,806.09%
GlobeImmune, Inc. GlobeImmune, Inc.
$719,817 $575.00
Alphabet Inc. Alphabet Inc.
GOOG
$4.139T +719,817,309,683.48%
GlobeImmune, Inc. GlobeImmune, Inc.
$635,834 $575.00
Microsoft Corporation Microsoft Corporation
MSFT
$3.656T +635,833,684,982.96%
GlobeImmune, Inc. GlobeImmune, Inc.
$501,851 $575.00
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.886T +501,851,453,900.00%